Status:
COMPLETED
Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Center for Research Resources (NCRR)
Conditions:
Preeclampsia
Eligibility:
FEMALE
Brief Summary
The hypothesis of this study is that many plasma proteins are altered in concentration and structure in preeclampsia and the elucidation of these alterations will add to the poorly understood pathophy...
Detailed Description
Preeclampsia affects 7-10% of all pregnancies and is directly responsible for 50,000 maternal deaths and 900,000 perinatal deaths each year. Preeclampsia remains unpredictable and incurable except thr...
Eligibility Criteria
Inclusion
- 20-34 weeks completed gestational age
Exclusion
- Multiple gestation
- Chronic hypertension
- Diabetes
- Lupus
- Tobacco Use
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 9 2012
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT00719654
Start Date
August 1 2007
End Date
April 9 2012
Last Update
May 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425